Adnexal lesions are routinely encountered in general practice. Ultrasound is the first line of
investigation in determining the benign or malignant potential of an adnexal lesion. In the …

Advances in Quantum Chemistry presents surveys of current topics in this rapidly
developing field that has emerged at the cross section of the historically established areas of …

Ovarian cancer is the second most common gynecologic malignancy. It is the deadliest,
largely owing to late stage at the time of diagnosis. Ultrasound is modality of choice in the …

Background: Human epididymis protein 4 (HE4) is approved for clinical use with CA125 to
predict epithelial ovarian cancer in women with a pelvic mass or in remission after …

Medical imaging used to be primarily within the domain of radiology, but with the advent of
virtual pathology slides and telemedicine, imaging technology is expanding in the …

Chromosome 3-specific Not I microarray (NMA) containing 180 clones with 188 genes was
used in the study to analyze 18 high grade serous ovarian cancer (HGSOC) samples and 7 …

The concept of early detection of cancer holds great promise and intuitive appeal. However,
powerful biases can mislead clinicians when evaluating the efficacy of screening tests by …

OBJECTIVE: To examine the types of symptoms and diagnostic procedures reported in
Medicare claims 12 months before diagnosis for women with ovarian cancer by stage, and …

Screening for premalignant lesions or early invasive disease has the potential to reduce
mortality from cancer. Because of their ease of measurement, several biomarkers have been …

Background: Patients with chronic kidney disease (CKD) are at risk to progress to kidney
failure. We previously developed the Kidney Failure Risk Equation (KFRE) to predict …